The City - July 14, 2020
Caterina Minniti, M.D., comments on the challenges faced by patients with sickle-cell disease during the COVID-19 pandemic, including the disease's side effects that may put people at higher risk for complications and death. Dr. Minniti is professor of clinical medicine and of pediatrics at Einstein and director of the Sickle Cell Center for Adults at Montefiore.
Dr. Minniti's Profile
The New York Times - June 27, 2020
A column by Nicholas Kristof hails positive examples of Hispanic community members helping one another in difficult times, including the COVID-19 pandemic. He notes that Carmen Isasi, M.D., Ph.D., who studies LatinX populations, has seen Spanish-speaking churches in New York City offering food for those in need. Dr. Isasi is associate professor of epidemiology & population health and of pediatrics.
Dr. Isasi's Profile
Modern Healthcare - June 19, 2020
Will Southern, M.D., M.S., and Shitij Arora, M.B.B.S., comment on an unpublished U.K. study that found the steroid dexamethasone helped patients with severe COVID-19, a finding consistent with their upcoming paper on steroid use in Montefiore's hospitalized patients. Dr. Southern is professor of medicine and chief of the division of hospital medicine at Einstein and Montefiore. Dr. Arora is associate professor of medicine at Einstein and an internist at Montefiore.
Additional coverage includes WIRED
Dr. Southern's ProfileMore coverage on Dr. Southern
Wired - June 17, 2020
Priya Nori, M.D., explains that the FDA's decision to revoke its Emergency Use Authorization for hydroxychloroquine to treat COVID-19 will have little impact on clinicians, many of whom had already shied away from using the antimalarial drug. Dr. Nori is assistant professor of medicine at Einstein and medical director of the antibiotic stewardship program at Montefiore Health System.
Dr. Nori's ProfileMore coverage on Dr. Nori
US News & World Report - June 16, 2020
Nir Barzilai, M.D., co-authors an op-ed that calls for a national campaign to combat chronic disease and fund research on drugs that target age-related disease—measures that could help protect vulnerable populations from the ravages of COVID-19. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
WSJ - June 10, 2020
Harris Goldstein, M.D., and Brian Pelowski discuss Einstein's success in transforming a lab to provide viral transport medium after the New York City Economic Development Corporation requested the college's assistance for its initiative to produce 50,000 COVID-19 testing kits each week. Dr. Goldstein is associate dean for scientific resources and Mr. Pelowski is assistant dean for scientific operations.
Additional coverage of the initiative includes CBS NewYork, US News & World Report, NBC 4 New York, ABC7NewYork, PIX11, AMNewYork, The Staten Island Advance, Patch, Gothamist, WCBS880, The Daily News, and The New York Post.
Dr. Goldstein's ProfileMore coverage on Dr. Goldstein
Medscape - June 9, 2020
Gordon Tomaselli, M.D., discusses the potential use of a non-invasive magnetic stimulation technique to treat ventricular tachycardia, the accelerated or irregular heart rhythm condition that causes about 300,000 deaths annually in the United States. Dr. Tomaselli is the Marilyn and Stanley M. Katz Dean at Einstein and executive vice president and chief academic officer at Montefiore Medicine.
Dr. Tomaselli's ProfileMore coverage on Dr. Tomaselli
The New York Times - June 9, 2020
Philip Ozuah, M.D., Ph.D., recounts painful personal experiences of racism, addresses how the COVID-19 pandemic disproportionately hurt minorities, and shares his hopes for societal change in a New York Times op-ed. Dr. Ozuah is president and CEO of Montefiore Medicine.
Additional coverage on this story includes MSNBC
Dr. Ozuah's ProfileMore coverage on Dr. Ozuah
AMNY - June 8, 2020
Michael Price and the Price Family Foundation, longtime supporters of Albert Einstein College of Medicine, will match up to $1 million in donations to Einstein for research on the coronavirus.
Newsweek - June 3, 2020
Emmeline Ayers, M.P.H., comments on her study finding an association between some personality traits and the risk of developing motoric cognitive risk, a pre-dementia syndrome that affects gait and cognition. Ms. Ayers is principal associate in The Saul R. Korey Department of Neurology.
More CoverageDr. Ayers' profile
CBS New York - May 29, 2020
Einstein is providing a crucial element in COVID-19 testing kits—viral transport medium—as part of a New York City initiative to produce 50,000 kits each week. Einstein is currently the only academic institution involved in the project.
Additional coverage of the initiative includes US News & World Report, NBC 4 New York, ABC7NewYork, PIX11, AMNewYork, The Staten Island Advance, Patch, Gothamist, WCBS880, The Daily News, and The New York Post.
Kaiser Health News - May 28, 2020
Gary Kennedy, M.D., discusses ways to lessen the feelings of isolation, hopelessness, and sadness of older adults during the COVID-19 pandemic “lockdown.” Dr. Kennedy is professor of psychiatry and behavioral sciences at Einstein and director, division of geriatric psychiatry at Montefiore.
Additional coverage of Dr. Kennedy on COVID-19 includes The New York Times
Dr. Kennedy's ProfileMore coverage on Dr. Kennedy